Danaher Corporation Income Statement
DHR / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Danaher Corporation reported $24.6B in revenue and $3.6B in net income for FY2025. Revenue has grown at a 3.1% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $24.6B | $23.9B | $24.8B | $22.3B | $17.9B | $17.0B | $17.9B | $19.9B | $18.3B | $16.9B | $14.4B | $12.9B | $18.3B | $12.6B | $16.1B |
| Cost of Revenue | $10.0B | $9.7B | $9.6B | $9.8B | $7.9B | $7.5B | $7.9B | $7.5B | $6.9B | $7.5B | $6.7B | $6.0B | $8.9B | $6.1B | $7.9B |
| Gross Profit | $14.5B | $14.2B | $15.2B | $12.5B | $10.0B | $9.5B | $10.0B | $9.5B | $8.6B | $9.3B | $7.8B | $6.8B | $9.3B | $6.4B | $8.2B |
| SG&A Expense | $8.2B | $7.8B | $6.8B | $6.9B | $5.6B | $5.4B | $5.6B | $5.4B | $5.0B | $5.6B | $4.7B | $4.0B | $5.1B | $3.6B | $4.6B |
| R&D Expense | $1.6B | $1.6B | $1.5B | $1.3B | $1.1B | $1.1B | $1.1B | $1.1B | $956.4M | $975.1M | $861.4M | $769.4M | $1.1B | $774.0M | $1.0B |
| Operating Income | $4.7B | $4.9B | $6.4B | $4.2B | $3.3B | $3.1B | $3.3B | $3.1B | $2.6B | $2.7B | $2.2B | $2.0B | $3.1B | $2.0B | $2.6B |
| Interest Expense | - | - | $231.0M | $275.0M | $108.0M | $137.0M | $108.0M | $137.0M | $140.1M | $184.4M | $139.8M | $94.7M | $141.2M | $117.1M | $141.6M |
| Income Tax | $633.0M | $747.0M | $1.1B | $849.0M | $873.0M | $556.0M | $873.0M | $556.0M | $371.0M | $457.9M | $292.7M | $447.5M | $825.7M | $511.4M | $512.5M |
| Net Income | $3.6B | $3.9B | $6.4B | $3.6B | $3.0B | $2.7B | $3.0B | $2.7B | $2.5B | $2.6B | $3.4B | $2.6B | $2.7B | $1.8B | $2.2B |
| EPS (Basic) | $5.07 | $5.33 | $8.77 | $4.97 | $4.11 | $3.78 | $3.58 | $3.69 | $4.81 | $3.69 | $4.81 | $3.70 | $3.87 | $2.74 | $1.80 |
| EPS (Diluted) | $5.05 | $5.29 | $8.61 | $4.89 | $4.05 | $3.74 | $3.53 | $3.65 | $4.74 | $3.65 | $4.74 | $3.63 | $3.80 | $2.64 | $1.73 |
| Shares Outstanding | 706.9M | 719.1M | 728.3M | 715.0M | 711.0M | 695.5M | 701.5M | 696.6M | 692.2M | 692.2M | 686.8M | 704.3M | 698.1M | 687.7M | 656.4M |
| Gross Margin | 59.1% | 59.5% | 61.4% | 56.0% | 55.7% | 55.8% | 55.7% | 47.8% | 46.8% | 55.3% | 53.8% | 53.2% | 51.1% | 51.0% | 50.8% |
| Operating Margin | 19.1% | 20.4% | 25.7% | 19.0% | 18.3% | 17.9% | 18.3% | 15.4% | 14.0% | 16.2% | 15.0% | 15.9% | 17.1% | 16.3% | 16.3% |
| Profit Margin | 14.7% | 16.3% | 25.9% | 16.4% | 16.8% | 15.6% | 16.8% | 13.3% | 13.6% | 15.1% | 23.3% | 20.2% | 14.7% | 14.3% | 13.5% |